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Objectives: Shuttering occurs when a scallop or fenestration does not
align perfectly with the target vessel ostium and is potentially minimized by
stenting. The currently approved fenestrated endovascular aortic repair (f-
EVAR) platform usually uses a nonstented superior mesenteric artery
(SMA) scallop, thereby subjecting the SMA to risk of partial coverage.
We sought to describe the presence and degree of SMA shuttering during
f-EVAR.
Methods: Patients undergoing f-EVAR using the commercially avail-
able ZFEN device containing an SMA scallop at our institution were
included for analysis. Corrected multiplanar coronal images on postopera-
tive computed tomography angiography were reviewed to measure SMA
shuttering, deﬁned as the percentage of SMA ostial diameter covered by
the stent graft fabric (Fig).
Results: Of the 24 f-EVAR cases performed during the study
period, 14 patients (71% male) had an SMA scallop to include in this
analysis (mean age, 75 years; mean abdominal aortic aneurysm size, 6.4Table. Preoperative variables and postoperative outcomes after HYBRID and T
Open thoracoabdominal (TAR) All patie
COPD
(n ¼ 154)
No COPD
(n ¼ 421) P
HYBRID
(n ¼ 27)
Age 71.1 (7.7) 69.0 (10.6) .01 73.9 (8.1)
Albumin 3.7 (0.5) 3.8 (0.6) .03 3.67 (0.5)
Steroids 13 (8.4%) 13 (3.1%) .006 1 (3.7%
ASA class 4/5 82 (53.3%) 175 (41.7%) .01 12 (44.4
Operative time, hours 5.9 (2.6) 5.8 (2.4) .86 7.0 (1.7)
Mortality 18 (11.7%) 40 (9.5%) .44 6 (22.2
Stroke 5 (3.3%) 9 (2.1%) .54 3 (11.1
Prolonged intubation 71 (46.1) 138 (32.8%) .003 8 (29.6
(% or SEM)
Fig. Percent superior mesenteric artery (SMA) shuttering
approximated by the SMA length outside the fenestration (B)
divided by the total SMA ostial diameter (B+C). Scallop width is
represented by letter A.
558cm). Thirty-nine vessels were targeted (14 SMA scallops, 25 renal fenes-
trations), with covered stents placed in all fenestrations. Target vessel
catheterization was achieved in 100% of cases. SMA shuttering of any
amount occurred in 64% of patients (range, 24%-54%). Degree of SMA
shuttering varied: no patients had 1% to 20%, four had 21% to 40%,
and ﬁve had 41% to 60%. All celiac and SMA vessels were patent on post-
operative imaging. On univariate analysis, there was no association be-
tween SMA shuttering and the measured clock position of the SMA or
renal arteries, percentage of device oversizing, number of renal artery fen-
estrations/stents, aneurysm neck morphology, or aortic diameter at the
SMA or proximal seal. No clinical events of mesenteric ischemia were
noted in any of the patients.
Conclusions: Even with the custom design of currently available
fenestrated technology, shuttering of the SMA occurred in more than half
of the patients, although no clinical events were noted. Further detail
with regards to the incidence, magnitude, and tolerance of SMA shuttering
during f-EVAR is warranted to fully understand the clinical implication of
this radiographic ﬁnding. Future design considerations for advanced
EVAR should take into account SMA shuttering to further reﬁne operative
planning.
Thoracoabdominal Aneurysm Repair in Patients with COPD:
Traditional Open Repair or Hybrid?
Bao-Ngoc Nguyen, MD, Richard F. Neville, MD, Rodeen Rahbar, MD,
Richard Amdur, PhD, Anton N. Sidawy, MD, MPH. George Washington
University, Wash, D.C.
Objectives: Open thoracoabdominal aneurysm repair (TAR) results
in major postoperative pulmonary complications in chronic obstructive pul-
monary disease (COPD) patients. This study investigates whether a hybrid
procedure (HYBRID) is a good alternative for this patient population.
Methods: All patients who underwent TAR (Current Procedural Ter-
minology code 33877) and HYBRID (visceral debranching and thoracic
endovascular aortic repair) from 2005 to 2010 were identiﬁed from the
National Surgical Quality Improvement Program database. Outcomes for
TAR were compared between patients with and without COPD. For
COPD patients, 30-day outcomes were compared between the TAR and
HYBRID approach.
Results: Of 575 patients who received TAR, 154 (27%) had COPD.
Compared with patients without COPD, patients with COPD were older,
more likely to be malnourished, use steroids, and have American Society of
Anesthesiologists class 4 or 5. COPD resulted in a signiﬁcantly higher risk
of prolonged intubation (46% vs 33%; P ¼ .003). When HYBRID (n ¼
27) was compared with TAR (n ¼ 575) for all patients, it had a signiﬁ-
cantly longer operative time (7.0 6 1.7 vs 5.8 6 2.4 hours; P ¼
.0017), higher risk of stroke (11.1% vs 2.4%; P ¼ .008), and no signiﬁcant
difference in pulmonary complications (Table). Furthermore, for COPDAR
nts (with and without COPD) COPD patients only
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69.5 (10.0) .03 74.0 (7.6) 71.1 (7.8) .28
3.8 (0.6) .49 3.9 (0.5) 3.7 (0.5) .51
) 26 (4.5%) .99 1 (11.1%) 13 (8.4%) .56
%) 257 (44.8%) .97 5 (55.6%) 82 (53.3%) .99
5.8 (2.4) .002 6.8 (2.1) 5.9 (2.6) .29
%) 58 (10.1%) 0.06 3 (33.3%) 18 (11.7%) .09
%) 14 (2.4%) .008 3 (33.3%) 5 (3.3%) .01
%) 209 (36.4%) .48 6 (66.7%) 71 (46.1%) .31
